Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 10 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)CompletedNCT00098839Phase 1/2Results posted
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell TransplantCompletedNCT00096161Phase 2Results posted
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesCompletedNCT00096135Not applicableResults posted
- MDX-010 in Treating Patients With Recurrent or Refractory LymphomaTerminatedNCT00089076Phase 1/2Results posted
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
- Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaCompletedNCT00075725Phase 3Results posted
- Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00075478Phase 3Results posted
- Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00073918Phase 2Results posted
- Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesCompletedNCT00072514Phase 2Results posted
- Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell TransplantCompletedNCT00068718Phase 1/2Results posted
- Randomized Double Cord Blood Transplant StudyCompletedNCT00067002Phase 2Results posted
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00061945Phase 1/2Results posted
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaCompletedNCT00057811Phase 2Results posted
- Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin LymphomaCompletedNCT00054639Phase 2Results posted
- Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
- Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesCompletedNCT00040846Phase 2Results posted
- Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00039377Phase 2Results posted
- Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic LeukemiaCompletedNCT00038610Phase 2Results posted
- Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibCompletedNCT00036738Phase 2Results posted
- Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaCompletedNCT00004228Phase 3Results posted
- Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedNCT00003838Phase 2Results posted
- Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or LymphomaCompletedNCT00002766Phase 3Results posted
- Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT07882069Not applicable
- A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In GreeceActive, not recruitingNCT07814170Not applicable
- A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsCompletedNCT07644351
- A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute LeukemiaWithdrawnNCT07498465Phase 1
- A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic LeukemiaWithdrawnNCT07428486Phase 1
- Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction PhaseTerminatedNCT07320534Phase 4
- A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute LeukemiaCompletedNCT07295951Phase 1
- A Multi-center Retrospective Study of INO Treating B-ALLActive, not recruitingNCT07238907
- Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic LeukemiaSuspendedNCT07192237Phase 2
- Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic LeukemiaActive, not recruitingNCT07166419Phase 1
- The Effect of Child-centered Empowerment on Lifestyle of Leukemia PatientsCompletedNCT07162558Not applicable
- Squishy Toy and Palpation in Pediatric IV SuccessCompletedNCT07041216Not applicable
- A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia PatientsCompletedNCT07039383
- Biomarkers in Patients With Anemia-Induced Thrombocytopenic BleedingActive, not recruitingNCT06947044Not applicable
- Hepatoprotective Measures for Children at High Risk of NAFLDActive, not recruitingNCT06918080Phase 4
- Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT06865352Phase 1/2
- Effects of Core Stabilization Exercises in Children With Acute Lymphoblastic LeukemiaCompletedNCT06794762Not applicable
- Physical Activity in Acute Lymphoblastic Leukemia (ALL)CompletedNCT06783738Not applicable
- CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I TrialActive, not recruitingNCT06765876Early Phase 1
- Psychiatric Problems in Children With Acute Lymphoblastic Leukemia and Their CaregiversActive, not recruitingNCT06723496
- A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative DisordersCompletedNCT06705530Phase 1/2
- ABBA CORD: dCBT w/ Abatacept for aGVHD ProphylaxisSuspendedNCT06680661Phase 2
- Effects of Home-Based Exercise Program in Children After Acute Lymphoblastic LeukemiaCompletedNCT06664736Not applicable
- Evaluating the Effectiveness of Respiratory Muscle Training in Pediatric Kidney Transplant PatientCompletedNCT06655181Not applicable
- A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at HomeSuspendedNCT06639958Not applicable
- CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell NeoplasmsStatus unknownNCT06593145Phase 1
- TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)CompletedNCT06578351
- Daratumumab for T Cell ALL With MRD-positive After Standard ChemotherapyWithdrawnNCT06570915Phase 2
- A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous TreatmentActive, not recruitingNCT06539338Phase 1
- A Study of PD5K3 in Healthy Adult VolunteersCompletedNCT06527781Phase 1
- MRD Detection by NGS in Pediatric T-ALLCompletedNCT06525116
- Psychometric Properties of the Therapy-Related Symptom Checklist-ChildrenCompletedNCT06488456
- COVID-19 and Childhood CancerActive, not recruitingNCT06482281
- A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.Active, not recruitingNCT06476665
- Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With HemoblastosisActive, not recruitingNCT06475820Phase 2/3
- An Endotracheal Tube Inserted to the Level of the HypopharynxCompletedNCT06449924
- Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaSuspendedNCT06447987Phase 1
- Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS DataCompletedNCT06392763
- Retun-to-school Adaptation Program for Children With CancerCompletedNCT06389357Not applicable
- Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic LeukemiaCompletedNCT06338020Not applicable
- Long Term Safety and Efficacy of KSM-66 Ashwagandha in AdultsCompletedNCT06244147
- Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)WithdrawnNCT06210750Phase 2
- Safety and Feasibility of TMLI as Conditioning Regimen in Allogeneic Hematopoietic Stem-cell TransplantationCompletedNCT06209190Not applicable
- Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic SyndromeSuspendedNCT06195891Phase 1
- Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALLCompletedNCT06195735
- Reduce Sedentary Time in Acute Lymphoblastic LeukemiaCompletedNCT06182163Not applicable
- Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected CommunitiesCompletedNCT06179732Phase 3
- Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic LeukemiaActive, not recruitingNCT06110182
- Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HDCompletedNCT06093334Not applicable
- A Study of BN104 in the Treatment of Acute LeukemiaActive, not recruitingNCT06052813Phase 1/2
- The Occurrence of Emergence Agitation in Pediatric Strabismus SurgeryCompletedNCT06035757Phase 4
- Difficult PIV Placement in the Pediatric EDWithdrawnNCT06013904Not applicable
- Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer SurvivorsActive, not recruitingNCT06002828
- HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisActive, not recruitingNCT06001385Phase 2
- Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic LeukemiaActive, not recruitingNCT05993949Phase 1
- Pediatric Kidney TransplantStatus unknownNCT05977387
- MRD Detection by NGS in Pediatric B-ALLCompletedNCT05973032
- Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyCompletedNCT05972577Not applicable
- Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute LeukemiasCompletedNCT05969002
- TCRαβ/CD19 Depletion of Stem Cell Grafts for TransplantWithdrawnNCT05968170Not applicable
- Cardiac Rehabilitation of Children and Adolescent With Long QT SyndromeCompletedNCT05964322
- A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaWithdrawnNCT05961696Phase 1
- Physical Exercise and Dairy Probiotics in Childhood Cancer SurvivorsCompletedNCT05939791Not applicable
- Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell TherapyWithdrawnNCT05936229Phase 1/2
- High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHDWithdrawnNCT05895201Phase 1/2
- A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)Active, not recruitingNCT05885464Phase 1/2
- Cord Blood Transplant in Adults With Blood CancersActive, not recruitingNCT05884333Phase 2
- Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab ConsolidationStatus unknownNCT05837689
- Registry of Relapsed/Refractory T-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05832125
- Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in ChildrenCompletedNCT05818644
- Anti-mullerian Hormone in Acute Lymphoblastic LeukemiaStatus unknownNCT05793463
- Observational Study of People Living With HIV Treated With CD19-directed CAR T CellCompletedNCT05784415
- Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid TumorsCompletedNCT05775406Phase 1
- Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia TreatmentCompletedNCT05774990
- Clinical Significance of Occult Central Nervous System LocalizationStatus unknownNCT05772000
- Childhood Cancer Survivors' Affective Response to ExerciseActive, not recruitingNCT05763290
- A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaActive, not recruitingNCT05761171Phase 2
- Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negativeCompletedNCT05750706